GeneDx Holdings Corp (NASDAQ: WGS) is -18.92% lower on its value in year-to-date trading and has touched a low of $16.65 and a high of $117.75 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The WGS stock was last observed hovering at around $66.85 in the last trading session, with the day’s loss setting it -4.53%.
Currently trading at $62.32, the stock is -33.95% and -34.50% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.33 million and changing -6.78% at the moment leaves the stock -8.28% off its SMA200. WGS registered 466.55% gain for a year compared to 6-month gain of 11.17%. The firm has a 50-day simple moving average (SMA 50) of $95.1503 and a 200-day simple moving average (SMA200) of $67.949524.
The stock witnessed a -26.33% loss in the last 1 month and extending the period to 3 months gives it a -19.96%, and is -43.03% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 12.63% over the week and 10.12% over the month.
GeneDx Holdings Corp (WGS) has around 1000 employees, a market worth around $1.78B and $305.45M in sales. Fwd P/E is 30.67. Profit margin for the company is -17.12%. Distance from 52-week low is 274.29% and -47.07% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.60%).
with sales reaching $85.93M over the same period.The EPS is expected to grow by 314.80% this year, but quarterly earnings will post 20.54% year-over-year. Quarterly sales are estimated to grow 21.86% in year-over-year returns.
275.0 institutions hold shares in GeneDx Holdings Corp (WGS), with institutional investors hold 99.47% of the company’s shares. The shares outstanding are 28.02M, and float is at 24.94M with Short Float at 13.04%. Institutions hold 86.84% of the Float.
The top institutional shareholder in the company is CASDIN CAPITAL, LLC with over 3.53 million shares valued at $92.18 million. The investor’s holdings represent 13.2482 of the WGS Shares outstanding. As of 2024-06-30, the second largest holder is CORVEX MANAGEMENT LP with 2.47 million shares valued at $64.66 million to account for 9.2937 of the shares outstanding. The other top investors are ORACLE INVESTMENT MANAGEMENT INC which holds 1.11 million shares representing 4.1542 and valued at over $28.9 million, while GOLDMAN SACHS GROUP INC holds 3.9517 of the shares totaling 1.05 million with a market value of $27.5 million.
GeneDx Holdings Corp (WGS) Insider Activity
The most recent transaction is an insider sale by Feeley Kevin, the company’s CHIEF FINANCIAL OFFICER. SEC filings show that Feeley Kevin sold 388 shares of the company’s common stock on Apr 29 ’25 at a price of $113.09 per share for a total of $43879.0. Following the sale, the insider now owns 3337.0 shares.
GeneDx Holdings Corp disclosed in a document filed with the SEC on Apr 29 ’25 that Stueland Katherine (Chief Executive Officer) sold a total of 2,154 shares of the company’s common stock. The trade occurred on Apr 29 ’25 and was made at $113.09 per share for $0.24 million. Following the transaction, the insider now directly holds 3440.0 shares of the WGS stock.
Still, SEC filings show that on Apr 29 ’25, Kevin Feeley (Officer) Proposed Sale 388 shares at an average price of $113.14 for $43900.0. The insider now directly holds shares of GeneDx Holdings Corp (WGS).
